Unité de Fabrication des Médicaments S.A (BVMT:UMED)

BVMT:UMED Income Statement

Financials in millions TND. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	153.79	147.68	136	96.36	84.5	91.04
Other Revenue	-0.09	-	-	-	0.01	-
Revenue	153.7	147.68	136	96.36	84.51	91.04
Revenue Growth (YoY)	8.91%	8.58%	41.14%	14.02%	-7.17%	-15.07%
Cost of Revenue	65.82	66.87	61.72	46.8	38.22	43.69
Gross Profit	87.87	80.8	74.29	49.56	46.29	47.35
Selling, General & Admin	21.13	21.11	19.71	16.77	15.48	15.1
Other Operating Expenses	9.63	9.85	9.88	8.27	6.87	8.37
Operating Expenses	49.84	47.43	45.18	35.95	32.55	34.03
Operating Income	38.03	33.37	29.11	13.61	13.74	13.33
Interest Expense	-6.94	-6.9	-6.22	-3.6	-2.63	-3.74
Interest & Investment Income	0.89	0.32	0.09	0.19	0.28	0.01
Currency Exchange Gain (Loss)	0.18	0.18	-0.48	-0.05	-0.48	0.33
Other Non Operating Income (Expenses)	0.23	0.09	-11.3	-0.22	-0.45	-0.69
EBT Excluding Unusual Items	32.4	27.07	11.21	9.94	10.47	9.23
Gain (Loss) on Sale of Assets	-	-	0.08	0.09	0.04	0.08
Asset Writedown	-0.1	-0.1	-0.3	-0.2	-0.08	-0.04
Pretax Income	32.29	26.97	10.99	9.83	10.43	9.27
Income Tax Expense	10.08	7.6	5.45	2	1.72	2.29
Earnings From Continuing Operations	22.22	19.37	5.55	7.83	8.7	6.98
Net Income	22.22	19.37	5.55	7.83	8.7	6.98
Net Income to Common	22.22	19.37	5.55	7.83	8.7	6.98
Net Income Growth	245.33%	249.30%	-29.17%	-10.03%	24.69%	-60.55%
Shares Outstanding (Basic)	-	32	32	32	32	32
Shares Outstanding (Diluted)	-	32	32	32	32	32
EPS (Basic)	-	0.61	0.17	0.24	0.27	0.22
EPS (Diluted)	-	0.61	0.17	0.24	0.27	0.22
EPS Growth	-	249.31%	-29.17%	-10.03%	24.69%	-60.55%
Free Cash Flow	11.93	10.58	18.68	-12.07	15.13	0.08
Free Cash Flow Per Share	-	0.33	0.58	-0.38	0.47	0.00
Dividend Per Share	0.570	0.570	-	0.469	0.406	-
Dividend Growth	-	-	-	15.52%	-	-
Gross Margin	57.17%	54.72%	54.62%	51.43%	54.77%	52.01%
Operating Margin	24.75%	22.60%	21.40%	14.12%	16.26%	14.64%
Profit Margin	14.45%	13.12%	4.08%	8.13%	10.30%	7.67%
Free Cash Flow Margin	7.76%	7.16%	13.73%	-12.52%	17.90%	0.09%
EBITDA	50.67	43.39	39.11	23.3	23.02	22.79
EBITDA Margin	32.97%	29.39%	28.75%	24.19%	27.24%	25.03%
D&A For EBITDA	12.64	10.02	10	9.69	9.27	9.46
EBIT	38.03	33.37	29.11	13.61	13.74	13.33
EBIT Margin	24.75%	22.60%	21.40%	14.12%	16.26%	14.64%
Effective Tax Rate	31.21%	28.17%	49.56%	20.35%	16.52%	24.74%
Revenue as Reported	153.89	147.87	136.15	96.62	84.55	91.07

Updated Dec 31, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.